miR-363 confers taxane resistance in ovarian cancer by targeting the Hippo pathway member, LATS2

Ovarian cancer is the most aggressive female reproductive tract tumours. Taxane (paclitaxel; TX) is widely used for ovarian cancer treatment. However, ovarian cancers often acquire chemoresistance. MicroRNAs (miR) have been reported to mediate many tumours’chemoresistance. We investigated the role o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Mohamed, Zeinab, Hassan, Mohamed Kamel, Okasha, Safwat, Mitamura, Takashi, Keshk, Sarah, Konno, Yusuke, Kato, Tatsuya, EL-Khamisy, Sherif F., Ohba, Yusuke, Watari, Hidemichi
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2018
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6059020/
https://ncbi.nlm.nih.gov/pubmed/30046387
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25698
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados